Pharmacy Benefits Management Services Home

Efficacy and Bleeding in DVT Prophylaxis: The RECORD clinical development program included four phase 3, double-blind, randomized, controlled trials that studied over 12,000 patients for the use of rivaroxaban vs. enoxaparin for the prevention of VTE in patients undergoing THR (RECORD 1 and 2) or TKR (RECORD 3 and 4) surgery. ................
................